While the treatment landscape for people with hereditary angioedema (HAE) has improved significantly in the last decades, symptoms such as…
Articles by Patricia Inácio, PhD
Acquired angioedema was the first sign of an underlying extranodal marginal zone lymphoma (EMZL) — a type of non-Hodgkin…
New hereditary angioedema (HAE) preventive treatment Dawnzera (donidalorsen) will now be available in the U.S. to adults and adolescents,…
Hereditary angioedema (HAE) patients who took Takhzyro (lanadelumab-flyo) for at least three years saw reductions in the frequency and…
The oral on-demand treatment candidate sebetralstat for hereditary angioedema (HAE) is getting to keep its orphan drug status in the…
Delays in administering on-demand treatment are common in hereditary angioedema (HAE), with 51% of patients receiving treatment more than…
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended that sebetralstat be approved…
A woman was diagnosed with hereditary angioedema (HAE) 20 years after her first symptoms, according to a case report…
The first patient has been dosed in a Phase 3 clinical trial testing NTLA-2002, Intellia Therapeutics’ gene-editing treatment candidate…
Astria Therapeutics is on track to start a Phase 3 clinical trial of navenibart, its therapy to prevent swelling…